100 Followers on Owler

Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers...

Read more

Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers...

Read more

Reapplix News

Reapplix Press Releases

Reapplix Headquarters

Blokken 45

Birkerod, Capital Region3460

45-88-16-80-66

Driving Directions »

Reapplix Summary

ABOUT

Overview

Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers. Reapplix was founded in 2008. Reapplix's headquarters is located in Birkerod, Capital Region, DK 3460. Re...

CEO

Reapplix's CEO, Kira Rupprecht, currently has an approval rating of 82%. Reapplix's primary competitors are Swift, Tissue Analytics & eKare, Inc..

Acquisitions

There have been no acquisitions found related to Reapplix

Investments

Recent investment data cannot be found related to Reapplix

Frequently Asked Questions about Reapplix

  1. When was Reapplix founded?

    Reapplix was founded in 2008
  2. Who is Reapplix's CEO?

    Reapplix's CEO is Kira Rupprecht
  3. How much revenue does Reapplix generate?

    Reapplix generates $10M in revenue
  4. How much funding does Reapplix have?

    Reapplix has historically raised $25.6M in funding
  1. Where is Reapplix's headquarters?

    Reapplix's headquarters is in Birkerod Capital Region, DK
  2. How many employees does Reapplix have?

    Reapplix has 50 employees
  3. What sector does Reapplix operate in?

    Reapplix is in Biotechnology
  4. Who are Reapplix's competitors?

    Reapplix's top competitors are Swift, Tissue Analytics, eKare, Inc.

Trending Companies